SCHEMBL29529630

SCHEMBL29529630

Cc1c(Br)cc(C(=O)O)cc1C(F)(F)F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.49
TTR P02766 1/20 0.47
MAPT P10636 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HTT P42858 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
TPMT P51580 2/20 0.41
LMNA P02545 2/20 0.41
ALKBH5 Q6P6C2 1/20 0.40
TAS2R14 Q9NYV8 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
XBP1 P17861 1/20 0.38
ASPH Q12797 1/20 0.38
PTGFR P43088 1/20 0.37
EPHX1 P07099 2/20 0.36
HCAR1 Q9BXC0 1/20 0.36
GPR35 Q9HC97 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22400615 1.00 NOTUM (0.49) NOTUMTTRMAPTMEN1KMT2A
SCHEMBL29528597 0.81 NOTUM (0.69) NOTUMMAPTMEN1KMT2AHTT
SCHEMBL22400332 0.81 NOTUM (0.69) NOTUMMAPTMEN1KMT2AHTT
SCHEMBL1071876 0.80 TTR (0.62) NOTUMTTRMAPTKMT2ATPMT
SCHEMBL26047383 0.80 TPMT (0.42) NOTUMMAPTMEN1KMT2AHTT
SCHEMBL3310108 0.80 TTR (0.48) NOTUMTTRMAPTMEN1KMT2A
SCHEMBL23699555 0.79 TTR (0.52) NOTUMTTRMAPTKMT2ATPMT
Hydrochloric Acid SCHEMBL11632990 0.79 TTR (0.47) NOTUMTTRMAPTMEN1KMT2A
SCHEMBL16528303 0.76 TTR (0.44) NOTUMTTRMAPTMEN1KMT2A
SCHEMBL22400336 0.76 TTR (0.44) NOTUMTTRMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746849-A1 PHARMACEUTICAL COMPOSITIONS OF INSULIN DERIVATIVES Novo Nordisk A/S (DK) 2026-05-27 EP disclosed
EP-4702045-A1 GLUCOSE SENSITIVE INSULIN DERIVATIVES Novo Nordisk A/S (DK) 2026-03-04 EP disclosed
WO-2025016992-A1 PHARMACEUTICAL COMPOSITIONS OF INSULIN DERIVATIVES NOVO NORDISK A/S (DK) 2025-01-23 WO disclosed
WO-2024223511-A1 GLUCOSE SENSITIVE INSULIN DERIVATIVES NOVO NORDISK A/S (DK) 2024-10-31 WO disclosed
CN-115490709-A KRASG12D inhibitor and application thereof in medicine 四川海思科制药有限公司 2022-12-20 CN disclosed
EP-3946363-A2 GLUCOSE SENSITIVE INSULIN DERIVATIVES Novo Nordisk A/S (DK) 2022-02-09 EP disclosed